Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction

被引：1
|
作者：
Bhatt, Ankeet S. [1 ,2 ,3 ]
Vaduganathan, Muthiah [4 ]
Jena, Barada Prasad [5 ]
Suminska, Sylwia [6 ]
Eid, Carlos [7 ]
Khairnar, Rahul [8 ]
Farries, Gabriella [6 ]
Senni, Michele [9 ]
机构：
[1] Kaiser Permanente San Francisco Med Ctr, San Francisco, CA USA
[2] Div Res, San Francisco, CA USA
[3] Stanford Univ, Sch Med, Div Cardiovasc Med, Palo Alto, CA USA
[4] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA
[5] Novartis Global Serv Ctr, Hyderabad, India
[6] Novartis Corp Ctr, Dublin, Ireland
[7] Novartis Pharm Serv AG, Off Middle East & North Afr, Nairobi, Kenya
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Univ Milano Bicocca, Osped Papa Giovanni XXIII, Bergamo, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷 / 05期
关键词：
D O I：
10.1002/ejhf.3233
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1172 / 1174
页数：3
相关论文
共 50 条
  • [31] Initiation, Continuation, or Withdrawal of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
    Gilstrap, Lauren G.
    Fonawow, Gregg C.
    Li, Liang
    DeVore, Adam
    Smith, Eric E.
    Heidenreich, Paul
    Hernandez, Adrian F.
    Yancy, Clyde W.
    Bhatt, Deepak L.
    CIRCULATION, 2016, 134
  • [32] Initiation, Continuation, or Withdrawal of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
    Gilstrap, Lauren G.
    Fonawow, Gregg C.
    Li, Liang
    DeVore, Adam
    Smith, Eric E.
    Heidenreich, Paul
    Hernandez, Adrian F.
    Yancy, Clyde W.
    Bhatt, Deepak L.
    CIRCULATION, 2016, 134
  • [33] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH HYPERTENSION
    Sanchez, Andres M. Cordova
    Shmorgon, Gary
    Olonoff, Danielle A.
    Ramm, Matthew
    Gualan, Carlos Merino
    Chaudhuri, Debanik
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2074 - 2074
  • [34] Angiotensin-converting enzyme inhibitors in female patients with diabetes mellitus in reduced ejection fraction heart failure
    Kozdag, G. Guliz
    Ural, D.
    Karauzum, I.
    Karauzum, K.
    Kahraman, G.
    Kilic, T.
    Wiley, J.
    Sanina, C.
    Baydemir, C.
    Vural, A.
    Agir, A. Agacdiken
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 247 - 247
  • [35] Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review
    Zhirov, Igor V.
    Safronova, Natalia V.
    Tereshchenko, Sergey N.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (09) : 802 - 809
  • [36] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure
    McClellan, MB
    Loeb, JM
    Clancy, CM
    Francis, GS
    Jacobs, AK
    Kizer, KW
    O'Kane, ME
    Wolk, MJ
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 386 - 387
  • [37] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for heart failure patients with different left ventricular ejection fraction categories: from the KCHF Registry
    Yoshikawa, Y.
    Tamaki, Y.
    Yaku, H.
    Yamamoto, E.
    Ozasa, N.
    Inuzuka, Y.
    Morimoto, T.
    Kato, T.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 374 - 374
  • [38] Association between prognosis and the use of angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blocker in frail patients with heart failure with preserved ejection fraction
    Sunaga, A.
    Hikoso, S.
    Tamaki, S.
    Yano, M.
    Hayashi, T.
    Oeun, B.
    Kida, H.
    Sotomi, Y.
    Dohi, T.
    Okada, K.
    Mizuno, H.
    Nakatani, D.
    Yamada, T.
    Yasumura, Y.
    Sakata, Y.
    EUROPEAN HEART JOURNAL, 2022, 43 : 770 - 770
  • [39] A Propensity-Matched Study of the Comparative Effectiveness of Angiotensin Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Heart Failure Patients Age ≥65 Years
    Zhang, Yan
    Fonarow, Gregg C.
    Sanders, Paul W.
    Farahmand, Firoozeh
    Allman, Richard M.
    Aban, Inmaculada B.
    Love, Thomas E.
    Levesque, Raynald
    Kilgore, Meredith L.
    Ahmed, Ali
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (10): : 1443 - 1448
  • [40] Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan
    Yang, Mingming
    Butt, Jawad H.
    Kondo, Toru
    Jering, Karola S.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Claggett, Brian L.
    Desai, Akshay S.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Petersson, Magnus
    Shah, Sanjiv J.
    Vaduganathan, Muthiah
    Wilderang, Ulrica
    Solomon, Scott D.
    McMurray, John J., V
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2307 - 2319
12345